Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial
Crossref DOI link: https://doi.org/10.1007/s10875-015-0160-6
Published Online: 2015-04-17
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lalazar, Gadi
Mizrahi, Meir
Turgeman, Ilit
Adar, Tomer
Ben Ya’acov, Ami
Shabat, Yehudit
Nimer, Assy
Hemed, Nila
Zolotarovya, Lidya
Lichtenstein, Yoav
Lisovoder, Nadya
Samira, Sarit
Shalit, Itamar
Ellis, Ronald
Ilan, Yaron
Text and Data Mining valid from 2015-04-17